Mark Jeeves

Mark Jeeves

Auto-generated profile, based on publicly available information

Mark Jeeves

Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, B15 2TT, UK

Research Focus & Metrics

Academic Career Length

31Years (1996-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 April 2008 in Molecular Microbiology
Verified
Journal Article
Open access
PDF file
TKTimothy J. Knowles
Timothy J. Knowles
MJMark Jeeves
Mark Jeeves
SBSaeeda Bobat
Saeeda Bobat
FDFelician Dancea
Felician Dancea
DMDarren McClelland
Darren McClelland
IHIan R. Henderson
Ian R. Henderson
Summary: Membranes of Gram‐negative bacteria, mitochondria and chloroplasts receive and fold β‐barrel transmembrane proteins through the action of polypeptide transport‐associated (POTRA) domains. In Escherichia coli, folding substrates are inserted into the outer membrane by the essential protein YaeT, a prototypic Omp85 protein. Here, the articulation between tandem POTRA domains in solution is defined by nuclear magnetic resonance (NMR) spectroscopy, indicating an unprecedented juxtaposition. The novel solution orientations of all five POTRA domains are revealed by small‐angle X‐ray scattering of the entire 46 kDa periplasmic region. NMR titration studies show that strands from YaeT's canonical folding substrate, PhoE, bind non‐specifically along alternating sides of its mixed β sheets, thus providing an ideal platform for helping to fold nascent outer‐membrane proteins. Together, this provides the first structural model of how multiple POTRA domains recruit substrates from the periplasmic solution into the outer membrane.

7 January 2011 in EMBO Reports
Verified
Journal Article
Closed access
PDF file
TKTimothy J Knowles
Timothy J Knowles
DBDouglas F Browning
Douglas F Browning
MJMark Jeeves
Mark Jeeves
RMRiyaz Maderbocus
Riyaz Maderbocus
SRSandya Rajesh
Sandya Rajesh
MOMichael Overduin
Michael Overduin

1 September 2017 in ACS Chemical Biology
Verified
Journal Article
Closed access
MSMahboob Salim
Mahboob Salim
TKTimothy J Knowles
Timothy J Knowles
ABAlfie T. Baker
Alfie T. Baker
MDMartin Davey
Martin Davey
MJMark Jeeves
Mark Jeeves
BWBenjamin E. Willcox
Benjamin E. Willcox

1 July 2005 in Journal of Molecular Biology
Verified
Journal Article
Closed access
CNChristine M. Nunn
Christine M. Nunn
MJMark Jeeves
Mark Jeeves
MCMatthew J. Cliff
Matthew J. Cliff
GUGillian T. Urquhart
Gillian T. Urquhart
RGRoger R. George
Roger R. George
SDSnezana Djordjevic
Snezana Djordjevic

28 March 2023 in Cell Reports
Verified
Journal Article
Open access
CWCarrie Willcox
Carrie Willcox
MSMahboob Salim
Mahboob Salim
CBCharlotte R. Begley
Charlotte R. Begley
MKMohindar M. Karunakaran
Mohindar M. Karunakaran
EEEmily J. Easton
Emily J. Easton
BWBenjamin E. Willcox
Benjamin E. Willcox
Vγ9Vδ2 T cells play critical roles in microbial immunity by detecting target cells exposed to pathogen-derived phosphoantigens (P-Ags). Target cell expression of BTN3A1, the "P-Ag sensor," and BTN2A1, a direct ligand for T cell receptor (TCR) Vγ9, is essential for this process; however, the molecular mechanisms involved are unclear. Here, we characterize BTN2A1 interactions with Vγ9Vδ2 TCR and BTN3A1. Nuclear magnetic resonance (NMR), modeling, and mutagenesis establish a BTN2A1-immunoglobulin V (IgV)/BTN3A1-IgV structural model compatible with their cell-surface association in cis. However, TCR and BTN3A1-IgV binding to BTN2A1-IgV is mutually exclusive, owing to binding site proximity and overlap. Moreover, mutagenesis indicates that the BTN2A1-IgV/BTN3A1-IgV interaction is non-essential for recognition but instead identifies a molecular surface on BTN3A1-IgV essential to P-Ag sensing. These results establish a critical role for BTN3A-IgV in P-Ag sensing, in mediating direct or indirect interactions with the γδ-TCR. They support a composite-ligand model whereby intracellular P-Ag detection coordinates weak extracellular germline TCR/BTN2A1 and clonotypically influenced TCR/BTN3A-mediated interactions to initiate Vγ9Vδ2 TCR triggering.

27 September 2018 in Blood
Verified
Journal Article
Closed access
PDF file
MGMitchell J. Geer
Mitchell J. Geer
JGJohanna P. van Geffen
Johanna P. van Geffen
PGPiraveen Gopalasingam
Piraveen Gopalasingam
TVTimo Vögtle
Timo Vögtle
CSChristopher W. Smith
Christopher W. Smith
YSYotis Senis
Yotis Senis
The immunoreceptor tyrosine-based inhibitory motif (ITIM)–containing receptor G6b-B has emerged as a key regulator of platelet homeostasis. However, it remains unclear how it mediates its effects. Tyrosine phosphorylation of ITIM and immunoreceptor tyrosine-based switch motif (ITSM) within the cytoplasmic tail of G6b-B provides a docking site for Src homology 2 domain–containing protein-tyrosine phosphatases Shp1 and Shp2, which are also critical regulators of platelet production and function. In this study, we investigate the physiological consequences of uncoupling G6b-B from Shp1 and Shp2. To address this, we generated a transgenic mouse model expressing a mutant form of G6b-B in which tyrosine residues 212 and 238 within ITIM and ITSM were mutated to phenylalanine. Mice homozygous for the mutation (G6b-B diY/F) were macrothrombocytopenic, as a result of the reduction in platelet production, and had large clusters of megakaryocytes and myelofibrosis at sites of hematopoiesis, similar to those observed in G6b-deficient mice and patients. Platelets from G6b-B diY/F mice were hyporesponsive to collagen, as a result of the significant reduction in the expression of the immunoreceptor tyrosine-based activation motif (ITAM)–containing collagen receptor complex GPVI–FcR γ-chain, as well as thrombin, which could be partially rescued by costimulating the platelets with adenosine diphosphate. In contrast, platelets from G6b-B diY/F, G6b KO, and megakaryocyte-specific Shp2 KO mice were hyperresponsive to antibody-mediated cross-linking of the hemi-ITAM–containing podoplanin receptor CLEC-2, suggesting that G6b-B inhibits CLEC-2–mediated platelet activation through Shp2. Findings from this study demonstrate that G6b-B must engage with Shp1 and Shp2 to mediate its regulatory effects on platelet homeostasis. Publisher9s Note: There is a Blood Commentary on this article in this issue. Key Points Uncoupling of G6b-B from Shp1 and Shp2 results in severe macrothrombocytopenia and aberrant platelet function. G6b-B inhibits CLEC-2 signaling primarily through the protein-tyrosine phosphatase Shp2. Visual Abstract